Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
Our common shares are quoted on the OTC Pink Quotation System under the symbol “VISM,” but trade infrequently.
The high and low bid prices of our common stock for the periods indicated below are as follows:
Fiscal Year Ended June 30, 2022
High
Low
Quarter Ended September 30, 2021
$ 28.35
$ 5.94
Quarter Ended December 31, 2021
$ 14.58
$ 3.78
Quarter Ended March 31, 2022
$ 8.64
$ 2.16
Quarter Ended June 30, 2022
$ 8.64
$ 1.35
Fiscal Year Ended June 30, 2021
High
Low
Quarter Ended September 30, 2020
$ 2.295
$ 0.54
Quarter Ended December 31, 2020
$ 14.715
$ 0.54
Quarter Ended March 31, 2021
$ 67.50
$ 0.54
Quarter Ended June 30, 2021
$ 27.00
$ 6.885
Stockholders
As of September 30, 2022, there were 14,800 stockholders of record of our Common Stock.
Dividend Policy
We have not paid any cash dividends and do not anticipate or contemplate paying dividends in the foreseeable future.
Recent Sales of Unregistered Securities
During the year ended June 30, 2022 the Company issued 146,701 shares of its common stock related to the conversion of $828,797 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $5.66 per share. The fair value of the shares issued was $2,422,722.
Stock Based Compensation and Stock Based Consulting Services Expense
During the year ended June 30 2022, the Company issued 53,334 shares of its $0.0001 par value common stock to three consultants, as compensation for services rendered. The shares were valued at $241,800, or $4.53 per share.
During the year ended June 30, 2022 the Company issued 54,955 shares of its $0.0001 par value common stock to six employees, as compensation for services rendered. The shares were valued at $762,833, or $13.88 per share.
During the year ended June 30, 2022 the Company issued 100,758 shares of its $0.0001 par value common stock to our Directors and Officer, as compensation for services rendered. The shares were valued at $1,173,800, or $11.65 per share.
Warrants
During the fiscal year ended June 30, 2022 the Company issued 4,881 shares of its $0.0001 par value common stock pursuant to the cashless exercise of warrants. The warrant shares were valued at $211,411, or $43.32 per share.
Funding
In September 2021 the Company entered into two securities purchase agreement (the “Purchase Agreements”) with a single institutional investor (the “Purchaser”) resulting in the raise of $1,500,000 in gross proceeds to the Company. Pursuant to the terms of the Purchase Agreements, the Company agreed to sell, in a registered director offering, an aggregate of 222,222 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at a purchase price of $6.75 per Share (the “Offering”). The Offerings closed on September 15 2021, and September 27 2021, respectively.
During the fiscal year ended June 30 2022, the Company issued 86,667 shares of its $0.0001 par value common stock to three investors as commitment shares pursuant to the issuance of promissory notes. The shares were valued at $330,959, or $3.82 per share.
Litigation Settlement
During the fiscal year ended June 30 2022, we issued 44,444 shares of its common stock pursuant to the settlement of litigation with ASC Recap.
Rule 10B-18 Transactions
During the year ended June 30, 2022, there were no repurchases of the Company’s common stock by the Company.
Item 6. Selected Financial Data.
As a “smaller reporting company”, we are not required to provide information required by this item.
9
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.